A 54-year-old male is evaluated on hospital day 4 for altered mental status. He was origin… — USMLE Step 3

A $54$ -year-old male is evaluated on hospital day $4$ for altered mental status. He was originally admitted for severe alcohol withdrawal complicated by generalized tonic-clonic seizures. The patient was successfully stabilized with intravenous lorazepam followed by a loading dose of phenytoin, and he is currently receiving an oral phenytoin maintenance regimen. His medical history is significant for severe alcohol use disorder and decompensated cirrhosis. Today, the nursing staff notes that the patient is increasingly confused, lethargic, and dysarthric. When attempting to walk to the bathroom, he exhibited a wide-based, unsteady gait. Vital signs are within normal limits. Neurologic examination reveals prominent bilateral horizontal nystagmus. Asterixis is absent. Laboratory studies show the following:

Laboratory Test	Result	Reference Range
Albumin	$1.9\text{ g/dL}$	$3.5-5.0\text{ g/dL}$
Total bilirubin	$3.5\text{ mg/dL}$	$0.1-1.2\text{ mg/dL}$
Ammonia	$35\text{ \mu mol/L}$	$15-45\text{ \mu mol/L}$
Total serum phenytoin	$11\text{ mg/L}$	$10-20\text{ mg/L}$

Which of the following is the most appropriate next step in the management of this patient?

Measure serum free phenytoin concentrationAnswer
B
Increase the oral phenytoin maintenance dose
C
Obtain a noncontrast computed tomography scan of the head
D
Administer oral lactulose
E
Initiate concomitant valproic acid therapy

Answer

The most appropriate next step is to measure the serum free phenytoin concentration to accurately assess for drug toxicity in the setting of severe hypoalbuminemia.

This patient presents with classic manifestations of phenytoin toxicity, including altered mental status, horizontal nystagmus, dysarthria, and ataxia. While his total serum phenytoin level of

11\text{ mg/L}

appears to be within the normal therapeutic range (

10-20\text{ mg/L}

), this value is deceiving due to his underlying severe cirrhosis and resulting hypoalbuminemia. Phenytoin is approximately

90\%

bound to plasma proteins, primarily albumin. In disease states characterized by low albumin (e.g., decompensated cirrhosis, nephrotic syndrome, severe malnutrition), the fraction of unbound, active phenytoin increases significantly. The standard laboratory test for phenytoin measures the total concentration (bound plus unbound). Therefore, a seemingly normal total phenytoin level in a patient with an albumin of

1.9\text{ g/dL}

represents a massive increase in the free, pharmacologically active drug crossing the blood-brain barrier. The most appropriate next step in treatment evaluation is to order a serum free phenytoin concentration, which provides an accurate assessment of the drug's true systemic exposure and confirms the diagnosis of toxicity.

Step-by-Step Solution

Analyze the patient's clinical presentation.

The patient exhibits confusion, dysarthria, ataxia, and horizontal nystagmus.

These findings are classic, hallmark signs of phenytoin toxicity.

Evaluate the laboratory results in the context of the medication regimen.

The total serum phenytoin level is

11\text{ mg/L}

, which falls within the standard therapeutic range of

10-20\text{ mg/L}

. However, the patient has profound hypoalbuminemia (

1.9\text{ g/dL}

Phenytoin is highly protein-bound in the serum. Evaluating the albumin level is crucial when interpreting total phenytoin levels.

Synthesize the pharmacokinetic principles to determine the next management step.

Because albumin is low, there are fewer binding sites for phenytoin. The absolute amount of unbound (free) phenytoin increases, penetrating the central nervous system and causing toxicity, even though the 'total' level appears normal. The next step is to measure the free phenytoin level.

Treatment evaluation and dose adjustments for highly protein-bound drugs in malnourished or cirrhotic patients must rely on the free fraction rather than the total fraction.

Key Concept

In patients with significant hypoalbuminemia, standard total serum phenytoin levels underestimate the amount of free (active) drug. Clinicians must measure free phenytoin levels or calculate an adjusted level to properly evaluate therapy and prevent severe toxicity.

Alternative Method

Instead of ordering a serum free phenytoin level, clinicians can quickly calculate the patient's estimated adjusted total phenytoin level using the Winter-Tozer equation: Adjusted Phenytoin = Measured Total Phenytoin / ((0.2 × Albumin) + 0.1). For this patient, the adjusted level would be 11 / ((0.2 × 1.9) + 0.1) = 11 / 0.48 = 22.9 mg/L. This calculated value exceeds the therapeutic upper limit of 20 mg/L, confirming clinical toxicity.

Estimated Time:2m 0s

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Alternative Method

Topics

More questions from this topic